05:04 PM EST, 03/06/2026 (MT Newswires) -- Andrea Ellis, Director, on March 04, 2026, sold 64,921 shares in Bridgebio Pharma ( BBIO ) for $4,211,302. Following the Form 4 filing with the SEC, Ellis has control over a total of 18,589 common shares of the company, with 18,589 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1743881/000147083126000252/xslF345X05/wk-form4_1772834274.xml